Cochrane COVID-19 Study Register
Study record
NCT05075304First Published: 2021 Oct 12Updated Date: 2021 Oct 12

A Phase Ib, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BDB-001 Injection in Patients With Novel Coronavirus (2019-nCoV) Infection

  1. Study Type
  2. Interventional
  1. Study Aim
  2. Treatment and Management
  1. Study Design
  2. Other
  1. Intervention Assignment
  2. Non-randomised
Reference record

A Safety and Tolerability Study of BDB-001 in Mild, Moderate COVID-19 Patients

Staidson (Beijing) Biopharmaceuticals Co., Ltd
First Published (first received 2021 October 12) (
Trial registry record
No Results
This open, multi-center, multiple ascending dose study was designed to evaluate the safety, tolerability, preliminary efficacy and PK/PD of BDB-001 injection in patients with mild, or general COVID-19